What should you know about secondary malignant neoplasm of liver and intrahepatic bile duct?

This diagnosis is also called liver metastasis or a secondary cancer in the liver. It is not the same as a cancer that began in liver cells or bile-duct cells. Cancers such as bowel or pancreatic cancer can spread to the liver, and the tumour cells usually retain features of their original site.

Some people have no symptoms and the deposits are found on a scan. Others notice tiredness, reduced appetite, discomfort under the ribs, weight change, jaundice, dark urine, pale stools or itching. These symptoms can have other causes. Blood tests, scans and sometimes a biopsy help establish the source, number, location and effect on liver function.

Ask which cancer started the spread and whether the liver is the only affected organ. Treatment may use chemotherapy or another systemic treatment directed at the original cancer. When deposits are limited and in suitable positions, liver resection or tumour ablation may be considered. The team weighs liver function, the relationship to blood vessels and bile ducts, and your general health before recommending a local procedure.

Bring previous pathology and scan reports to appointments, and keep a list of medicines and supplements. Report appetite changes, abdominal discomfort, bowel changes, itching or yellowing early so the team can assess them.

Seek urgent help for new confusion, severe abdominal pain, vomiting blood, black stools, fainting, rapidly worsening jaundice or inability to keep fluids down. Contact the oncology team promptly for fever, increasing swelling of the abdomen, new bleeding or marked reduction in alertness or daily function.

Where did the cancer begin, and how is that confirmed? What do the scans show in the liver and elsewhere? How is liver function being monitored? Could resection or ablation be suitable? What is the purpose of chemotherapy? Which changes should prompt an urgent call?